Author(s): Bernard Crespi*

Abstract

New neuroimaging technique studies brain stimulation for depression. TAMPA, Fla. (May 4, 2021) -- Repetitive transcranial magnetic stimulation, or rTMS, was FDA approved in 2008 as a safe and effective noninvasive treatment for severe depression resistant to antidepressant medications. The study of published in the journal Scientific Reports. Repetitive transcranial magnetic stimulation, or rTMS, was FDA approved in 2008 as a safe and effective non-invasive treatment for sever depression resistant to antidepressant medications. Keyword: Neuroimaging, dysthymi

Share this article